http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017093902-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f0d1964c25696c35eb233f1b895090c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1818
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18
filingDate 2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afe66159f92e5589e64be84202ac12f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea92425be4cb0f2ed0dcbfcfb4d2a48b
publicationDate 2017-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017093902-A1
titleOfInvention A process for the preparation of nanoparticles for use as contrast agents in the magnetic resonance imaging
abstract The present invention relates to a process for preparing nanoparticles of a polysaccharide crosslinked with a suitable crosslinking agent, inside which a gadolinium- or manganese-based contrast agent is geometrically confined; this process of preparation is based on the use of microfluidic devices and on the control of temperatures, flows and respective concentrations in the several steps of the process, so as to obtain a final product having nanometric size wherein the metal, thanks to its geometric confinement in the crosslinked polysaccharide lattice, has an increased relaxivity, useful for increasing the contrast of images in the magnetic resonance imaging, or in combination with other imaging diagnostic techniques or more in general in nuclear medicine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-202100002537-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109568608-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109568608-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022167536-A2
priorityDate 2015-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015004103-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011158901-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013040295-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012173933-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007150030-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15908

Total number of triples: 25.